May 23, 2022

Volume XII, Number 143

Advertisement
Advertisement

May 20, 2022

Subscribe to Latest Legal News and Analysis
Advertisement

First Patent to Survive Post Grant Review

Congratulations to Paragon BioTeck Inc.  Its US Patent No. 8,859,623 has survived a post grant review challenge brought by Altaire Pharmaceuticals.  In only its 4th written decision, the PTAB found that Altaire did not prove that the Paragon patent claims were invalid as obvious in light of Altaire's earlier products. 

Altaire Pharmaceuticals Inc. v. Paragon BioTeck Inc., PGR2015-00011

© Copyright 2022 Armstrong Teasdale LLP. All rights reserved National Law Review, Volume VI, Number 321
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Jennifer E. Hoekel, Intellectual Property Attorney, Armstrong Teasdale law firm
Partner

A member of the firm’s Intellectual Property Litigation practice group and a registered U.S. patent attorney, Jennifer Hoekel focuses on patent litigation.

Finding her general litigation background to be an asset in this practice area, she has litigated patents, trademarks, copyrights, trade secrets, unfair competition and license acquisition matters, in state, federal and appellate courts throughout the U.S. Her cases involve mechanical, electrical, chemical and business method patents in such varied subject matter as cholesterol inhibiting substances, highway roadside safety...

314-342-4162
Advertisement
Advertisement
Advertisement